Monday, August 10, 2020 5:48:48 PM
$INO | #Inovio Pharma a Risky Hold into Earnings
Stock is sitting at a very critical level as earnings approach.
A drop below $19.00 could see a sharp drop to the Fibonacci Golden pocket at $16.00 or to the POC (redline) @ $13.87
Risky hold into earnings
Inovio Pharmaceuticals , Inc. is a late-stage biotechnology company. It engages in the discovery , development, and commercialization of DNA-based immunotherapies and vaccines. The firm's drug candidates include SynCon immunotherapies which helps break the immune system’s tolerance of cancerous cells; and CELLECTRA delivery system which facilitates optimized cellular uptake of the SynCon immunotherapies. The company was founded by David B. Weiner on June 29, 1983 and is headquartered in Plymouth Meeting, PA.
Official InvestorsHub (IHUB) Profile for #TFMG | #theFinancialMarketingGroup:
#BullishCharts - https://investorshub.advfn.com/BullishChartscom-38003/
#TopMarketGainers - https://investorshub.advfn.com/Chart-Analysis-TopMarketGainerscom-36847/
Recent INO News
FEATURED POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • Jun 26, 2024 10:09 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
